MedTrace Logo

Clinical Trial of an Automated Smartphone Based Smoking Cessation Treatment

NCT02930200 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 98

Last updated 2019-06-20

No results posted yet for this study

Summary

The primary long-term objective of this research is to reduce smoking relapse through the use of automated mobile smoking cessation interventions that tailor content (e.g., treatment messages/materials) in real-time based upon currently present symptoms. The primary short-term objective of this pilot study is to determine the initial utility of a novel smartphone based smoking cessation intervention compared with standard in-person smoking cessation clinic care and the free National Cancer Institute (NCI) QuitGuide smoking cessation application. The current pilot study is a 3 armed randomized clinical trial that aims to determine the initial utility of a novel smartphone based smoking cessation intervention compared with standard in-person smoking cessation clinic care and the free NCI QuitGuide smoking cessation application.

Conditions

  • Smoking Cessation

Interventions

BEHAVIORAL

Treatment as Usual

Tobacco Treatment Research Program (TTRP) or Treatment as Usual (TAU)

BEHAVIORAL

QuitGuide

NCI QuitGuide Treatment App

BEHAVIORAL

Smart-T

Smart-Treatment App

Sponsors & Collaborators

  • University of Oklahoma

    lead OTHER

Principal Investigators

  • Michael Businelle, PhD · University of Oklahoma

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-05-30
Primary Completion
2018-11-01
Completion
2018-11-01

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02930200 on ClinicalTrials.gov